Velasco Cimica - Search Results

Year	Number of Results
2005	2
2006	1
2007	2
2008	1
2010	2
2011	3
2012	1
2013	1
2014	3
2015	1
2016	1
2017	1
2018	1
2020	1
2021	3
2024	0

1

Adjuvant formulations for virus-like particle (VLP) based vaccines.

Cimica V, Galarza JM. Cimica V, et al. Clin Immunol. 2017 Oct;183:99-108. doi: 10.1016/j.clim.2017.08.004. Epub 2017 Aug 3. Clin Immunol. 2017. PMID: 28780375 Free PMC article. Review.

2

Current development of Zika virus vaccines with special emphasis on virus-like particle technology.

Cimica V, Galarza JM, Rashid S, Stedman TT. Cimica V, et al. Expert Rev Vaccines. 2021 Nov;20(11):1483-1498. doi: 10.1080/14760584.2021.1945447. Epub 2021 Aug 9. Expert Rev Vaccines. 2021. PMID: 34148481 Review.

3

IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.

Petrenko O, Li J, Cimica V, Mena-Taboada P, Shin HY, D'Amico S, Reich NC. Petrenko O, et al. Among authors: cimica v. PLoS One. 2021 Mar 2;16(3):e0247394. doi: 10.1371/journal.pone.0247394. eCollection 2021. PLoS One. 2021. PMID: 33651821 Free PMC article.

4

Hantavirus interferon regulation and virulence determinants.

Mackow ER, Dalrymple NA, Cimica V, Matthys V, Gorbunova E, Gavrilovskaya I. Mackow ER, et al. Among authors: cimica v. Virus Res. 2014 Jul 17;187:65-71. doi: 10.1016/j.virusres.2013.12.041. Epub 2014 Jan 8. Virus Res. 2014. PMID: 24412542 Free PMC article.

5

A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model.

Cimica V, Saleem S, Matuczinski E, Adams-Fish D, McMahon C, Rashid S, Stedman TT. Cimica V, et al. Pathogens. 2021 May 31;10(6):680. doi: 10.3390/pathogens10060680. Pathogens. 2021. PMID: 34072726 Free PMC article.

6

Rhabdoid tumor growth is inhibited by flavopiridol.

Smith ME, Cimica V, Chinni S, Challagulla K, Mani S, Kalpana GV. Smith ME, et al. Among authors: cimica v. Clin Cancer Res. 2008 Jan 15;14(2):523-32. doi: 10.1158/1078-0432.CCR-07-1347. Clin Cancer Res. 2008. PMID: 18223228

7

Zika Virus-Like Particle (VLP) vaccine displaying Envelope (E) protein CD loop antigen elicits protective and specific immune response in a murine model.

Cimica V, Williams S, Adams-Fish D, McMahon C, Narayanan A, Rashid S, Stedman TT. Cimica V, et al. Biochem Biophys Res Commun. 2020 Aug 27;529(3):805-811. doi: 10.1016/j.bbrc.2020.05.161. Epub 2020 Jul 20. Biochem Biophys Res Commun. 2020. PMID: 32736711

8

Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.

Boigard H, Cimica V, Galarza JM. Boigard H, et al. Among authors: cimica v. Vaccine. 2018 Nov 29;36(50):7728-7736. doi: 10.1016/j.vaccine.2018.10.072. Epub 2018 Oct 28. Vaccine. 2018. PMID: 30377067 Free article.

9

Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.

Smith ME, Cimica V, Chinni S, Jana S, Koba W, Yang Z, Fine E, Zagzag D, Montagna C, Kalpana GV. Smith ME, et al. Among authors: cimica v. Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):319-24. doi: 10.1073/pnas.0913297108. Epub 2010 Dec 20. Proc Natl Acad Sci U S A. 2011. PMID: 21173237 Free PMC article.

10

An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein.

Cimica V, Dalrymple NA, Roth E, Nasonov A, Mackow ER. Cimica V, et al. mBio. 2014 Feb 18;5(1):e01088-13. doi: 10.1128/mBio.01088-13. mBio. 2014. PMID: 24549848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year